MWM
INMB icon

Modera Wealth Management’s INmune Bio INMB Stock Holding History

Modera Wealth Management’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9K Buy
+17,575
New +$25K ﹤0.01% 632
2025
Q4 		– Sell
-15,455
Closed -$32K – 654
2025
Q3 		$32K Hold
15,455
– – ﹤0.01% 642
2025
Q2 		$35.7K Buy
+15,455
New +$113K ﹤0.01% 641

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Modera Wealth Management's INMB Position: Q1 2026 in Review

Modera Wealth Management opened a new position in INmune Bio (INMB) in Q1 2026: 17,575 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #632 among its holdings. This is a return to the name: Modera Wealth Management previously reported a position in INMB as recently as Q3 2025.

Modera Wealth Management first reported a position in INMB in Q2 2025 and has held it in 3 quarters since. The position peaked at $35.7K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Modera Wealth Management held 17,575 shares of INmune Bio worth $19.9K as of Q1 2026.
  • INmune Bio was a new Modera Wealth Management position in Q1 2026.
  • INmune Bio made up ﹤0.01% of Modera Wealth Management's portfolio in Q1 2026, its #632 holding.
  • Modera Wealth Management first reported a position in INmune Bio in Q2 2025 and has held it in 3 quarters since.
  • Modera Wealth Management's INmune Bio position peaked at $35.7K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Modera Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.